Halozyme Therapeutics - 股票价格

HALO

40.23

每天都在变化:

-2.21%

每年:

107.48%

物价 天 年
Acadia Pharmaceuticals 56.00 0.14 0.25% 23.65%
Agios Pharmaceuticals 44.67 -0.99 -2.17% 14.83%
Alnylam Pharmaceuticals 129.86 4.41 3.52% 10.86%
Amgen 224.81 4.50 2.04% -4.22%
Amarin 4.60 0 0% -78.37%
Aptinyx Inc 3.42 0.12 3.64% -15.76%
Arena Pharmaceuticals 65.90 0.40 0.61% 39.09%
Baxter International 75.97 0.58 0.77% -7.32%
Cara Therapeutics 14.95 -0.10 -0.66% -42.46%
Cytokinetics 17.15 0.56 3.38% 77.35%
DBV Technologies 2.55 0.18 7.59% -67.31%
Esperion Therapeutics 26.80 -0.18 -0.67% -47.82%
Five Prime Therapeutics 19.07 0.62 3.36% 386.48%
Halozyme Therapeutics 40.23 -0.91 -2.21% 107.48%
Intercept Pharmaceuticals 37.27 -0.12 -0.32% -65.61%
Immunogen 5.52 0.22 4.15% 52.91%
Ionis Pharmaceuticals 50.60 0.36 0.72% -20.89%
Intra Cellular Therapies 24.98 -0.61 -2.38% 157.26%
Jazz Pharmaceuticals 135.00 7.42 5.23% -9.62%
Eli Lilly 147.44 2.69 1.86% 25.64%
MannKind 3.08 0.13 4.41% 150.41%
Minerva Neurosciences 4.01 0.08 2.04% -35.84%
Nektar Therapeutics 16.79 0.31 1.88% -17.25%
Pfizer 37.23 0.70 1.92% -3.35%
Peregrine Pharmaceuticals 8.94 0.16 1.82% 62.25%
Rigel Pharmaceuticals 3.11 0.18 6.14% 38.84%
United Therapeutics 135.54 0.47 0.35% 46.91%
Vanda Pharmaceuticals 12.41 0.30 2.48% -25.82%
Intrexon 7.49 0.01 0.13% 34.47%

物价 天 年
NASDAQ 12205 111.44 0.92% 40.86%
Russell 2000 1855 10.25 0.56% 14.21%

HALO:US
资产
现金及等价物
销售成本
当前资产
流动负债
债务
EBIT
EBITDA
员工
EPS每股收益
股本和储备
销售毛利
债务利息支出
贷款资金
市值
净收入
营业费用
营业利润
普通股股本
税前利润
销售收入
销售和管理费用
股票
贸易债权人
应收帐款